Beyond Air, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. (Nasdaq: XAIR) on September 26, 2024. The filing discloses the entry into a material definitive agreement for a private placement offering of equity securities.
Key Financial Metrics and Transaction Details
The filing details a capital raise rather than operational financial results. Key transaction metrics include:
- Gross Proceeds: $20,600,000.
- Securities Issued:
- 25,000,000 shares of Common Stock at $0.51 per share.
- 15,392,155 Pre-funded Warrants at $0.5099 per warrant (exercise price $0.0001).
- 40,392,155 Common Warrants (exercise price $0.38 per share).
- Placement Fees: 7.0% of gross proceeds plus reimbursement of out-of-pocket expenses up to $75,000.
- Expected Closing Date: On or about September 30, 2024.
The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes and Agreements
The primary material change is the execution of a Securities Purchase Agreement with accredited investors. Key terms include:
- Stockholder Approval Requirement: The Company must convene a stockholder meeting within 180 days of closing to approve an increase in authorized shares and the adjustment of the Common Warrant exercise price.
- Warrant Terms: Warrants are exercisable after stockholder approval. Common Warrants expire five years after the initial exercise date. Both warrant types allow for cashless exercise if no effective registration statement exists.
- Registration Rights: The Company must file a resale registration statement by October 26, 2024, with effectiveness required within 30 days (or 75 days if a full review is requested).
- Lock-Up Restrictions: The Company is restricted from issuing additional common stock or equivalents for 90 days post-closing or until the registration statement is effective, whichever is later.
Outlook, Risks, and Contingencies
Management commentary is limited to the mechanics of the offering. Significant risks and contingencies identified include:
- Liquidated Damages: The Company is obligated to pay liquidated damages if stockholder approval for the warrant proposals is not obtained within 180 days of closing, or if the registration statement is not filed or declared effective by the required deadlines.
- Dilution: The issuance of shares and warrants will result in significant dilution to existing shareholders.
- Anti-Dilution Provisions: The Common Warrant exercise price is subject to reduction via a weighted average formula if the Company issues stock at a price lower than the warrant exercise price.
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds received.
- Confirm the date and outcome of the stockholder meeting required to approve the Authorized Share Proposal and Warrant Proposal.
- Monitor the filing and effectiveness status of the resale Registration Statement (due by October 26, 2024).
- Review the full text of the Securities Purchase Agreement and Warrant forms (Exhibits 10.1, 4.1, and 4.2) for specific anti-dilution and liquidated damages calculations.
- Check for any subsequent filings regarding the use of proceeds or changes in the capital structure.